Tue, Jan 27, 2015, 9:58 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • dogledon dogledon Aug 25, 2013 2:28 PM Flag

    3 Biotech Stocks That May Go to Zero

    The Street put out a bash article. I am sure they all bought heavy on Friday and are prepared for their opening short sell to profit at least 10%.
    These s41t bash articles should be prosecuted.
    AE, Shatstein, and their minions in for a nice profit Monday morning.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This article was pulled shortly after I commented about it:

      "Interesting. Why pick these particular companies from the list of 10,000 that you cite?

      I don't know about the other two companies, but in the case of Celsion you are only telling a tiny part of the story, without any mention of their relationship with Hisun, or the VERY POSITIVE post-hoc trial subgroup results, which will be officially released in September at the most prestigious cancer conference in the world.

      The P3 trial was poorly conceived by the FDA and Celsion. RF ablation times were not a control (independent) variable, and it needed to be. RFA also needed to be administered closer to an hour after infusion rather than the 15-45 minute window for this trial. There still is a LOT of potential for this delivery mechanism and framework.

      Also, I believe your cash-burn rates are inflated by up to 50%. (They have enough cash to last 3-4 years at current burn rates.) And even so, the company has never had a problem raising funds.

      So, the prospect for Celsion stock going to zero is just about zero."

    • Not really bashing article but a bit confusing from the author.Everybody won't accept that CLSN is worthful. A lot of people lost their pants again and can't face up this time its gonna work...ahaha...since I trade bio never seen so many articles which take down a stock...Greed is bad.

      Sentiment: Strong Buy

    • That is a cheaply written article. The next closest therapy for liver cancer is Nexavar, its survival rate is just over %50. Look at the revenues it has generated(ONXX). not to mention AMGN is buying it away form other suitors. Maybe Amgen would buy little ol Celsion........

2.245+0.005(+0.22%)Jan 27 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Horizon Pharma plc
NASDAQTue, Jan 27, 2015 4:00 PM EST
Yahoo! Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST